Aster CMI Hospital, Datar Cancer Genetics launch cancer screening programme
04 February 2022 | News
A simple blood test to diagnose 30 types of cancer
Image credit: shutterstock
Aster CMI Hospital in association with Datar Cancer Genetics, a leading cancer research company, has launched comprehensive cancer screening programme.
The hospital is bringing in EasyCheck360 (multiple cancers), EasyCheck FemmeSafe (women’s) and EasyCheck Prostrate cancer screening tests. EasyCheck is a revolutionary, radiation-free, globally recognised simple blood test for early cancer detection.
It is clinically validated by one of the world’s largest clinical trials registered with the WHO clinical Trial Registry brought to you by Datar Cancer Genetics.
EasyCheck360 is a simple blood test that can detect more than 30 cancers. It is intended to be performed annually as a screening test, in individuals without any symptoms suggestive of cancer and aged > 30 years.
